☰

Xue Xia - Publications

Affiliations: 
2011-2015 Biomedical Sciences Florida State University, Tallahassee, FL, United States 
Tree Info Similar researchers PubMed Report error

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Xia X, Kumru OS, Blaber SI, Middaugh CR, Li L, Ornitz DM, Suh JM, Atkins AR, Downes M, Evans RM, Tenorio CA, Bienkiewicz E, Blaber M. An S116R Phosphorylation Site Mutation in Human Fibroblast Growth Factor-1 Differentially Affects Mitogenic and Glucose-Lowering Activities. Journal of Pharmaceutical Sciences. 105: 3507-3519. PMID 27773526 DOI: 10.1016/J.Xphs.2016.09.005  0.661
2016 Xia X, Kumru OS, Blaber SI, Middaugh CR, Li L, Ornitz DM, Sutherland MA, Tenorio CA, Blaber M. Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application. Journal of Pharmaceutical Sciences. 105: 1444-53. PMID 27019961 DOI: 10.1016/J.Xphs.2016.02.010  0.685
2016 Xia X, Longo LM, Sutherland MA, Blaber M. Evolution of a protein folding nucleus. Protein Science : a Publication of the Protein Society. 25: 1227-40. PMID 26610273 DOI: 10.1002/Pro.2848  0.645
2015 Xia X, Longo LM, Blaber M. Mutation choice to eliminate buried free cysteines in protein therapeutics. Journal of Pharmaceutical Sciences. 104: 566-76. PMID 25312595 DOI: 10.1002/Jps.24188  0.678
2012 Xia X, Babcock JP, Blaber SI, Harper KM, Blaber M. Pharmacokinetic properties of 2nd-generation fibroblast growth factor-1 mutants for therapeutic application. Plos One. 7: e48210. PMID 23133616 DOI: 10.1371/Journal.Pone.0048210  0.61
2012 Sipes RK, Xia X, Lewis BS, Burgis NE. Evidence that aberrant protein metabolism contributes to chemoresistance in multiple myeloma cells. Oncology Reports. 27: 2031-8. PMID 22426518 DOI: 10.3892/Or.2012.1716  0.3
Show low-probability matches.